Two Sigma Advisers’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-357,500
Closed -$1.54M 2474
2025
Q1
$1.54M Sell
357,500
-131,500
-27% -$531K ﹤0.01% 1263
2024
Q4
$1.56M Sell
489,000
-58,400
-11% -$196K ﹤0.01% 1244
2024
Q3
$1.57M Sell
547,400
-69,200
-11% -$194K ﹤0.01% 1202
2024
Q2
$1.73M Sell
616,600
-197,800
-24% -$531K ﹤0.01% 1267
2024
Q1
$2.31M Sell
814,400
-63,500
-7% -$216K 0.01% 1143
2023
Q4
$3.59M Sell
877,900
-104,300
-11% -$292K 0.01% 971
2023
Q3
$3.12M Sell
982,200
-63,300
-6% -$201K 0.01% 960
2023
Q2
$3.47M Sell
1,045,500
-39,500
-4% -$117K 0.01% 930
2023
Q1
$2.31M Buy
1,085,000
+222,100
+26% +$549K 0.01% 1202
2022
Q4
$2.32M Sell
862,900
-420,800
-33% -$1.23M 0.01% 1155
2022
Q3
$4.16M Buy
1,283,700
+361,800
+39% +$1.63M 0.01% 825
2022
Q2
$4.5M Buy
921,900
+72,500
+9% +$446K 0.01% 823
2022
Q1
$6.47M Sell
849,400
-145,400
-15% -$1.13M 0.02% 690
2021
Q4
$9.19M Buy
994,800
+66,800
+7% +$710K 0.02% 527
2021
Q3
$13.2M Buy
928,000
+208,800
+29% +$3.24M 0.03% 437
2021
Q2
$12M Buy
719,200
+406,200
+130% +$7.57M 0.03% 497
2021
Q1
$5.7M Buy
313,000
+254,300
+433% +$3.45M 0.02% 806
2020
Q4
$442K Buy
+58,700
New +$279K ﹤0.01% 1911
2020
Q3
Sell
-52,900
Closed -$203K 2574
2020
Q2
$203K Sell
52,900
-3,500
-6% -$12.6K ﹤0.01% 2246
2020
Q1
$182K Buy
56,400
+23,500
+71% +$101K ﹤0.01% 2193
2019
Q4
$158K Buy
+32,900
New +$208K ﹤0.01% 2222

Other funds holding ORGO

Two Sigma Advisers's ORGO Position: Q2 2025 in Review

Two Sigma Advisers sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 357,500 shares — an estimated $1.54M sold.

Two Sigma Advisers first reported a position in ORGO in Q4 2019 and held it in 21 quarters. The position peaked at $13.2M in Q3 2021. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • Two Sigma Advisers reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 357,500 Organogenesis Holdings shares in Q2 2025, an estimated $1.54M.
  • Two Sigma Advisers first reported a position in Organogenesis Holdings in Q4 2019 and held it in 21 quarters.
  • Two Sigma Advisers's Organogenesis Holdings position peaked at $13.2M in Q3 2021.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.